Administrative Core for a Program Project in Hematologic Cancers
Official title: Core A: Administration
Funded at Fred Hutchinson Cancer Center · NIH-11420372 · Data updated 2026-11-12
A central, money-and-meeting hub supports a team researching blood cancers by coordinating researchers, tracking progress, and ensuring NIH rules are followed.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 28, 1997 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $193,172 |
| NIH project number | 5P01CA018029-50 |
| Project ID | NIH-11420372 on NIH RePORTER |
Who could benefit from this research
✓Could help
This core is administrative and does not involve patient participation; however, the broader program may include patient-focused research.
✕Less likely to help
Patients would not directly participate in this core's activities.
What this research studies
This grant funds the Administrative Core of a Program Project focused on hematologic cancers. It helps investigators, collaborators, and advisors stay aligned through regular meetings, progress reviews, and clear communications. It also manages finances and NIH compliance so the scientific work can proceed smoothly and transparently. The core enables the team to focus on advancing understanding and treatment of blood cancers by keeping all projects and cores organized and well-governed.
Why it matters
Potential benefit: Improved coordination and compliance can accelerate progress toward better treatments for hematologic cancers.
How similar studies have gone: Administrative cores in multi-project cancer programs have historically improved efficiency and collaboration, enabling faster progression of scientific aims.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Hill, Geoffrey Roger — Fred Hutchinson Cancer Center
- Study coordinator: Hill, Geoffrey Roger
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.